Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in REPL — Replimune Group, Inc.

CIK 1109448 NASHVILLE, TN
Back to REPL Full portfolio

Position in REPL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$800,361
+$324,990 QoQ
Shares Held
72,300
+16.4% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 199 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. REPL ranks #142 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,019,315 $1,499,784,339
2 ARGX
Argenx SE
 395,661 $367,082,405
3 GMAB
Genmab A/S
 8,644,877 $237,474,771
4 REGN
Regeneron Pharmaceuticals, Inc.
 292,338 $182,284,436
5 TECH
BIO-TECHNE Corp
 2,002,026 $141,443,136
6 HALO
Halozyme Therapeutics, Inc.
 1,696,538 $132,788,029
7 KYMR
Kymera Therapeutics, Inc.
 981,521 $112,551,013
8 BBIO
BridgeBio Pharma, Inc.
 1,453,504 $108,256,977

All Filings in REPL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $800,361 72,300
2026-03-31 $475,371 62,140
2025-12-31 $604,000 62,140
2025-09-30 $266,232 63,540
2025-06-30 $478,342 51,490
2025-03-31 $1,384,509 142,001
2024-12-31 $5,335,811 440,612
2024-09-30 $5,359,538 489,009
2024-06-30 $611,820 67,980
2024-03-31 $381,784 46,730
2023-12-31 $393,933 46,730
2023-09-30 $2,777,705 162,344
2023-06-30 $1,085,070 46,730
2023-03-31 $655,698 37,129
2022-12-31 $865,748 31,829
2022-09-30 $531,916 30,800
2022-06-30 $538,384 30,800
2022-03-31 $453,366 26,700
2021-12-31 $723,570 26,700
2021-09-30 $791,388 26,700
2021-06-30 $1,129,548 29,400
2021-03-31 $503,415 16,500
2020-12-31 $949,935 24,900
2020-09-30 $563,990 24,500
2020-06-30 $641,130 25,800
2020-03-31 $185,442 18,600